Oxidation parameters in complete correction of renal anemia

Clinical Nephrology

Volumn 53, Issue SUPPL. 1, 2000, Pages

  Ludat, K ^a   Sommerburg, O ^a   Grune, T ^b   Siems, W G ^c   Riedel, E ^d   Hampl, H ^d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Glutathione disulfide; Malondialdehyde; Oxidative stress; Reduced glutathione; Renal anemia; RhEPO

Indexed keywords

FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; MALONALDEHYDE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ANTIOXIDANT ACTIVITY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS;

EID: 0034063873     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Baud L, Ardailhu R (1986) Reactive oxygen species: production and role in the kidney. Am J Physiol 257: F765-F776
2. BeutlerE. Duron O, Kelly BMXI963) Improved methods for the determination of blood glutathione. J Lab Clin Mol 61: 882-888
3. Canestrani F, Buoncristiani U, Galli F (1995) Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 234, 127-136
4. Cavdar C, Camsari T. Semin 1, Gonenc S, Acikgoz O (1997) Lipid peroxidation and antioxidant activity in chronic hemodialysis patients with recombinant human erythropoietin. Scand J Urol Nephrol 31: 371375
5. Claster S. Chin DT, Quintanila A, Lubin B (1984) Neutrophils mediate lipid oxidation in human red cells. Blood 64: 1079-1084
6. Costagiola C, RomanoL, Sorice P. Di Bcncdetto A (1989) Anemia and chronic renal failure: The possible role of the oxidative state of glutathione. Nephron 52: 11-14
7. Dasgupta A, Hussain S, Ahmad S ( 1992) Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 55: 56-59
8. Detmas Beam-mix MC, Combe C. Penchant E (1995) Evaluation of red blood cell lipid peroxidation in hemodialyzed patients during erythropoietin therapy supplemented or not with iron. Nephron 31:404-410
9. Esterbauer H, SchaiirR, Zöllner H ( 1991 ) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free Radie Biol Med 77: 81-128
10. Esterbauer H. Gebicki J, Fühl H. Jürgens G ( 1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radie Biol Med 13: 341-390
11. Haklar G. }'egenaga I, Yalcin AS (1995) Evaluation of oxidant stress in chronic hemodialysis patients: use of different parameters. Clin Chim Acta 234: 109-114
12. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS (1995) Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41: 1135-1138
13. Jacobson SH, Moldeus P (1994) Whole blood-, plasma-, and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis. Clin NephroU2: 189-192
14. Jiang JP, Downing SE (1990) Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med 63: 581-591
15. Kikugawa K, Kosugi H, Asakura T (1984) Effect of malondialdehyde, a product of lipid peroxidation on the function and stability of hemoglobin. Arch Biochem Biophys 229: 7-14
16. Komatsu H. Koo A. Ghadishah E et al (1992) Neutrophil accumulation in ischémie reperfused rat liver: evidence for a role for Superoxide free radicals. Am J Physiol 2d2: G669-G676
17. Lewis NP, McDougall 1C. Willis N, Henderson AH (1992) The ventilatory cost of exercise compared in chronic heart failure and chronic renal anemia. Q J Med 83: 523-531
18. Linos SL, Whittenbiirg D, Repine JE (1990) Role of xanthine oxidase in ischemia/rcperfusion injury. Am J Physiol 25S.-F711-F716
19. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER (1994) Oxidative stress in hemodialysis. Q J Med 87: 679-683
20. LuftR, Landau BR (1995) Mitochondrial medicine. J Intern Med 238,405-421
21. Maggi E., Bellazzi R, Ga:o A, Seccia M, Bellomo G (1994) Autoantibodies against oxidatively-modified LDL in urémie patients undergoing dialysis. Kidney Int 46: 869-876
22. NenovD, Paskalev D, Yankova T, Tchankova T (1995) Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment. Artif Organs 19:436-439
23. Panzetta O, Cominacini L, Garbin U (1995) Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis - effects of fish oil and vitamin E administration. Clin Nephrol 44, 303-309
24. PaulJL, Sail ND, Soni T et al (1993) Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 64: 106-109
25. RoselaarSE.NazhatNB, WinyardPG, Jones P, Cunningham J, Blake DR (1995) Detection of oxidants in urémie plasma by electron spin resonance spectroscopy. Kidney Int 48: 199-206
26. +-ATPase. Free Radie Biol Med 20: 215-233
27. Siems WG, Krämer K, Gmne J(1996b) Störungen im Glutathionsystem und klinische Konsequenzen [Glutathione system disturbances and clinical consequences]. Pharmazeut Z 141:4343-4352
28. Siems WG, Krämer K, Grüne T( 1996c) Zur Chemie und Biologie des Glutathionsystems - ein Überblick. [The chemistry and biology of the glutathione system - an overview]. Pharmazeut Z 141: 4239-4248
29. Siems WG, Krämer K, Grüne T, Esterbauer H (1997) Metabolie fate of 4-hydroxynonenaI in hepatocytes: l ,4-Dihydroxynonenal is not the main product. J Lipid Res 38:612-622
30. Siems WG, PimenovAM, Esterbauer H, Grüne J(1998) Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product in thymocytes as an effective secondary antioxidative defense mechanism. Biochemistry Tokyo 123:534-539
31. Sommerburg O, Grüne T, Klee S, Ungemach F. Siems WG ( 1993) Formation of 4-hydroxynonenal and further aldehydic mediators of inflammation during bromotrichloromethane treatment of rat liver cells. Mediators Inflamm 2: 27-31
32. Sommerburg O, Gmne T, Hampl H, Riedel E, van Kuijk FJ, Ehrich JHH, Siems WG (1998) Does long-term treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialyzed patients? Nephrol Dial Transplant 13: 2583-2587
33. Taccone Galtuci Af, Lubrano R, Trapasso E et al ( 1994) Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment. ASAIO J 40: M663-M666
34. Trachtmann H, Wilson D, Rao PS ( 1992) The role of oxygen-free radicals in the development of chronic renal failure. Life Sei 50: 1877-1883
35. Uchida K, Stadtman ER (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase: A possible involvement of intra- and intermolecular cross-linking reaction. J Biol Chem 268: 6388-6393
36. tt'estlni)en J, Adams CE, Flemming SJ ( 1995) Evidence for oxidative stress during in vitro dialysis. Nephron 70:49-54
37. ll'ong SH, Knight JA, Hopfer SM, Zaharia O, Leach Jr CN, Suiulerman Jr FW (1987) Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdhyde-thiobarbituric acid adduct. Clin Chem 33:214-220
38. Zachee P. Edmonds MP, Goossens W, Daelemanns R, Lins RL, Boogaerts MA (1988) Erythrocyte deformability and oxidative sensitivity in hemodialysis patients. Clin Hemorheol 8:439-443